No abstract available
Publication types
-
Letter
-
Observational Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use
-
C-Reactive Protein / genetics
-
C-Reactive Protein / metabolism*
-
COVID-19 / immunology
-
COVID-19 / therapy*
-
COVID-19 / virology
-
COVID-19 Drug Treatment
-
Humans
-
Interleukin-8 / antagonists & inhibitors
-
Interleukin-8 / blood*
-
Prospective Studies
-
SARS-CoV-2 / drug effects*
-
SARS-CoV-2 / isolation & purification
-
SARS-CoV-2 / pathogenicity
-
Serum Amyloid P-Component / genetics
-
Serum Amyloid P-Component / metabolism*
-
Survival Rate
-
Ventilators, Mechanical*
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents, Immunological
-
Interleukin-8
-
Serum Amyloid P-Component
-
PTX3 protein
-
C-Reactive Protein
-
siltuximab